Insider transactions

EDGAR

QUIDELORTHO CORP

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
8 transactions, 34,170 shares
Sum of shares × price per share: 826,015.482
Open-market sales (code S)
1 transactions, 4,026 shares
Sum of shares × price per share: 111,965.4756

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 157

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-15 Filed 2026-10-19Siegrist Jonathan Philip Officer: EVP of RD CTO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)18,6570—32,076Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 3.
Open filing 0002040321-26-000005 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Siegrist Jonathan Philip Officer: EVP of RD CTO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)6,69513.91
93,127.45

Derived: shares × price per share. Exact value 93127.45.

25,381Direct (D) No
F2
  • F2 Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Open filing 0002040321-26-000005 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Siegrist Jonathan Philip Officer: EVP of RD CTO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (18,657)
Disposed (D)18,6570—18,657Direct (D) No
F3, F4
  • F3 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F4 18,656 shares vested on October 15, 2025; 18,657 shares vested on October 15, 2026; and the remaining 18,657 shares will vest on October 15, 2027.
Open filing 0002040321-26-000005 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Bowman Ronald Lee Officer: Chief Human Resources Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,5660—5,941Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 4.
Open filing 0002036238-26-000005 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Bowman Ronald Lee Officer: Chief Human Resources Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)92110.63
9,790.23

Derived: shares × price per share. Exact value 9790.23.

5,020Direct (D) No
F2
  • F2 Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Open filing 0002036238-26-000005 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Bowman Ronald Lee Officer: Chief Human Resources Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (2,566)
Disposed (D)2,5660—2,566Direct (D) No
F3, F4
  • F3 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F4 2,565 shares vested on September 15, 2025; 2,566 shares vested on September 15, 2026; and the remaining 2,566 shares will vest on September 15, 2027.
Open filing 0002036238-26-000005 Read from the filing’s XML Dispute this row
2026-08-15 Filed 2026-08-18Hanson Bryan Michael Officer: EVP Global Port. Mgmt Mkting
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)4460—8,217Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 3.
Open filing 0002123618-26-000011 Read from the filing’s XML Dispute this row
2026-08-15 Filed 2026-08-18Hanson Bryan Michael Officer: EVP Global Port. Mgmt Mkting
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)16214.30
2,316.6

Derived: shares × price per share. Exact value 2316.60.

8,055Direct (D) No
F2
  • F2 Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Open filing 0002123618-26-000011 Read from the filing’s XML Dispute this row
2026-08-15 Filed 2026-08-18Hanson Bryan Michael Officer: EVP Global Port. Mgmt Mkting
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (446)
Disposed (D)4460—0Direct (D) No
F3, F4
  • F3 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F4 446 shares vested on August 15, 2026.
Open filing 0002123618-26-000011 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-16Young Micah W Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (356,555)
Acquired (A)356,5550—356,555Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 118,851 shares will vest on July 15, 2027, 118,852 shares will vest on July 15, 2028, and 118,852 shares will vest on July 15, 2029.
Open filing 0001717871-26-000006 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Hanson Bryan Michael Officer: EVP Global Port. Mgmt Mkting
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5,7970—9,867Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 3.
Open filing 0002123618-26-000009 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Hanson Bryan Michael Officer: EVP Global Port. Mgmt Mkting
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,09618.18
38,105.28

Derived: shares × price per share. Exact value 38105.28.

7,771Direct (D) No
F2
  • F2 Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Open filing 0002123618-26-000009 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Hanson Bryan Michael Officer: EVP Global Port. Mgmt Mkting
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (5,797)
Disposed (D)5,7970—11,595Direct (D) No
F3, F4
  • F3 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F4 5,797 shares vested on July 1, 2026, 5,797 shares will vest on July 1, 2027 and 5,798 shares will vest on July 1, 2028.
Open filing 0002123618-26-000009 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29BUECHLER KENNETH F Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Equity Grant) — underlying Common Stock (15,532)
Acquired (A)15,5320—15,532Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
Open filing 0001238916-26-000005 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29BUECHLER KENNETH F Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (12,204)
Acquired (A)12,2040—12,204Direct (D) No
F1, F3, F4
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
  • F4 3,051 shares vested on June 25, 2026, 3,051 shares will vest on September 25, 2026, 3,051 shares will vest on December 25, 2026, and 3,051 shares will vest on March 25, 2027.
Open filing 0001238916-26-000005 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29BUECHLER KENNETH F Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (3,661)
Acquired (A)3,6610—3,661Direct (D) No
F1, F2, F3
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
Open filing 0001238916-26-000005 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Chiminski John R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Equity Grant) — underlying Common Stock (15,532)
Acquired (A)15,5320—15,532Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
Open filing 0001482197-26-000003 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Chiminski John R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (5,547)
Acquired (A)5,5470—5,547Direct (D) No
F1, F3, F4
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
  • F4 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027.
Open filing 0001482197-26-000003 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Chiminski John R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (1,109)
Acquired (A)1,1090—1,109Direct (D) No
F1, F2, F3
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
Open filing 0001482197-26-000003 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29RHOADS ANN D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Equity Grant) — underlying Common Stock (15,532)
Acquired (A)15,5320—15,532Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
Open filing 0001250252-26-000007 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29RHOADS ANN D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (3,698)
Acquired (A)3,6980—3,698Direct (D) No
F1, F3, F4
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
  • F4 924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares will vest on December 25, 2026, and 925 shares will vest on March 25, 2027.
Open filing 0001250252-26-000007 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29RHOADS ANN D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (369)
Acquired (A)3690—369Direct (D) No
F1, F2, F3
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
Open filing 0001250252-26-000007 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Wilkins Joseph D Jr. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Equity Grant) — underlying Common Stock (15,532)
Acquired (A)15,5320—15,532Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
Open filing 0001848760-26-000003 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29POLAN MARY LAKE PH D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Equity Grant) — underlying Common Stock (15,532)
Acquired (A)15,5320—15,532Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
Open filing 0001187716-26-000005 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29POLAN MARY LAKE PH D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (5,547)
Acquired (A)5,5470—5,547Direct (D) No
F1, F3, F4
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
  • F4 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027.
Open filing 0001187716-26-000005 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29POLAN MARY LAKE PH D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (1,664)
Acquired (A)1,6640—1,664Direct (D) No
F1, F2, F3
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
Open filing 0001187716-26-000005 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Huennekens R Scott Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Equity Grant) — underlying Common Stock (15,532)
Acquired (A)15,5320—15,532Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
Open filing 0001365493-26-000008 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Dilsaver Evelyn S Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Equity Grant) — underlying Common Stock (15,532)
Acquired (A)15,5320—15,532Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
Open filing 0001391387-26-000010 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29WIDDER KENNETH J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Equity Grant) — underlying Common Stock (15,532)
Acquired (A)15,5320—15,532Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
Open filing 0001065168-26-000006 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29WIDDER KENNETH J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (6,656)
Acquired (A)6,6560—6,656Direct (D) No
F1, F3, F4
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
  • F4 1,664 shares vested on June 25, 2026, 1,664 shares will vest on September 25, 2026, 1,664 shares will vest on December 25, 2026, and 1,664 shares will vest on March 25, 2027.
Open filing 0001065168-26-000006 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29WIDDER KENNETH J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (1,997)
Acquired (A)1,9970—1,997Direct (D) No
F1, F2, F3
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
Open filing 0001065168-26-000006 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Michael Edward L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Equity Grant) — underlying Common Stock (15,532)
Acquired (A)15,5320—15,532Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
Open filing 0001391823-26-000005 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Michael Edward L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (3,513)
Acquired (A)3,5130—3,513Direct (D) No
F1, F3, F4
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
  • F4 878 shares vested on June 25, 2026, 878 shares will vest on September 25, 2026, 878 shares will vest on December 25, 2026, and 879 shares will vest on March 25, 2027.
Open filing 0001391823-26-000005 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Michael Edward L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (1,053)
Acquired (A)1,0530—1,053Direct (D) No
F1, F2, F3
  • F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F2 The restricted stock units will vest on June 25, 2027.
  • F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
Open filing 0001391823-26-000005 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09Michael Edward L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9630—29,144Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 4.
Open filing 0001391823-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09Michael Edward L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2890—29,433Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 4.
Open filing 0001391823-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09Michael Edward L. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (963)
Disposed (D)9630—0Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Open filing 0001391823-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09Michael Edward L. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (289)
Disposed (D)2890—0Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Open filing 0001391823-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09POLAN MARY LAKE PH D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7490—20,218Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 4.
Open filing 0001187716-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09POLAN MARY LAKE PH D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2240—20,442Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 4.
Open filing 0001187716-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09POLAN MARY LAKE PH D Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (749)
Disposed (D)7490—0Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Open filing 0001187716-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09POLAN MARY LAKE PH D Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (224)
Disposed (D)2240—0Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Open filing 0001187716-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09WIDDER KENNETH J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9100—44,800Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 4.
Open filing 0001065168-26-000005 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09WIDDER KENNETH J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2730—45,073Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 4.
Open filing 0001065168-26-000005 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09WIDDER KENNETH J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (910)
Disposed (D)9100—0Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Open filing 0001065168-26-000005 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09WIDDER KENNETH J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (273)
Disposed (D)2730—0Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Open filing 0001065168-26-000005 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09BUECHLER KENNETH F Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)1,6590—110,409Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 4.
Open filing 0001238916-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09BUECHLER KENNETH F Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4970—110,906Direct (D) No
F1
  • F1 Reflects release of restricted stock units that were previously reported on a Form 4.
Open filing 0001238916-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09BUECHLER KENNETH F Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units (Converted) — underlying Common Stock (1,659)
Disposed (D)1,6590—0Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Open filing 0001238916-26-000004 Read from the filing’s XML Dispute this row
2026-06-06 Filed 2026-06-09BUECHLER KENNETH F Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units (Premium) — underlying Common Stock (497)
Disposed (D)4970—0Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • F3 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Open filing 0001238916-26-000004 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 257

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager11,143,003 SH117,447,251 dollarsLower by 59,520 Prior quarter: 11,202,523Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager7,853,268 SH82,773,444 dollarsHigher by 4,546,189 Prior quarter: 3,307,079Open filing 0000748054-26-000009 Filed 2026-11-20 Dispute this row
Newtyn Management, LLC 5,342,283 SH56,307,663 dollarsLower by 1,282,717 Prior quarter: 6,625,000Open filing 0001493152-26-052329 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager3,950,168 SH41,634,767 dollarsLower by 3,413,528 Prior quarter: 7,363,696Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 3,635,778 SH38,321,100 dollarsLower by 499,686 Prior quarter: 4,135,464Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Invesco Ltd. Partly reported under another manager3,604,814 SH37,994,739 dollarsHigher by 131,382 Prior quarter: 3,473,432Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Rubric Capital Management LP 3,133,148 SH33,023,380 dollarsLower by 173,133 Prior quarter: 3,306,281Open filing 0001104659-26-128244 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager3,026,630 SH31,900,680 dollarsHigher by 47,991 Prior quarter: 2,978,639Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 3,015,589 SH31,784,308 dollarsLower by 54,465 Prior quarter: 3,070,054Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
NEUBERGER BERMAN GROUP LLC 2,949,874 SH31,097,325 dollarsLower by 584,745 Prior quarter: 3,534,619Open filing 0001465109-26-000128 Filed 2026-11-13 Dispute this row
PARADIGM CAPITAL MANAGEMENT INC/NY Partly reported under another manager2,390,300 SH25,193,762 dollarsLower by 131,400 Prior quarter: 2,521,700Open filing 0001037792-26-000017 Filed 2026-11-13 Dispute this row
PRIVATE MANAGEMENT GROUP INC Partly reported under another manager2,290,299 SH24,139,751 dollarsHigher by 219,908 Prior quarter: 2,070,391Open filing 0001142031-26-000022 Filed 2026-11-04 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager2,234,367 SH23,550,227 dollarsHigher by 1,169,623 Prior quarter: 1,064,744Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager1,946,967 SH20,521,034 dollarsHigher by 271,442 Prior quarter: 1,675,525Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,723,392 SH18,168,248 dollarsLower by 110,845 Prior quarter: 1,834,237Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
T. Rowe Price Investment Management, Inc. 1,443,257 SH15,212 dollarsLower by 300,306 Prior quarter: 1,743,563Open filing 0001897612-26-000766 Filed 2026-11-16 Dispute this row
SEGALL BRYANT HAMILL, LLC 1,302,258 SH13,725,799 dollarsLower by 43,272 Prior quarter: 1,345,530Open filing 0001006378-26-000010 Filed 2026-11-16 Dispute this row
GAGNON SECURITIES LLC 1,298,562 SH13,686,843 dollarsHigher by 268,191 Prior quarter: 1,030,371Open filing 0001019056-26-000150 Filed 2026-11-05 Dispute this row
Buckley Capital Advisors, LLC 1,221,097 SH12,870,362 dollarsHigher by 370,762 Prior quarter: 850,335Open filing 0002111611-26-000005 Filed 2026-11-13 Dispute this row
Allianz Asset Management GmbH Partly reported under another manager1,190,481 SH12,547,670 dollarsHigher by 64,256 Prior quarter: 1,126,225Open filing 0001193125-26-463640 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,181,628 SH12,454,359 dollarsHigher by 163,524 Prior quarter: 1,018,104Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
RICE HALL JAMES ASSOCIATES, LLC 1,023,501 SH10,787,701 dollarsLower by 40,058 Prior quarter: 1,063,559Open filing 0001172661-26-005283 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager838,755 SH8,840,760 dollarsLower by 414,928 Prior quarter: 1,253,683Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager756,926 SH7,977,999 dollarsHigher by 5,848 Prior quarter: 751,078Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
THOMPSON SIEGEL WALMSLEY LLC Partly reported under another manager730,181 SH7,696 dollarsHigher by 309,366 Prior quarter: 420,815Open filing 0001008322-26-000012 Filed 2026-11-05 Dispute this row
Point72 Asset Management, L.P. 593,964 SH6,260,381 dollarsHigher by 563,542 Prior quarter: 30,422Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 592,928 SH6,249,461 dollarsLower by 129,552 Prior quarter: 722,480Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
Skylands Capital, LLC 582,464 SH6,139,171 dollarsHigher by 22,050 Prior quarter: 560,414Open filing 0001821268-26-000195 Filed 2026-10-21 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager571,865 SH6,027,456 dollarsLower by 339,250 Prior quarter: 911,115Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
Gem Investment Advisors, LLC 506,036 SH5,333,619 dollarsLower by 59,962 Prior quarter: 565,998Open filing 0001580018-26-000007 Filed 2026-11-13 Dispute this row
Schonfeld Strategic Advisors LLC 486,073 SH5,123,208 dollarsNot in the prior quarter’s filings read Open filing 0001665241-26-000003 Filed 2026-11-16 Dispute this row
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. 462,395 SH4,873,643 dollarsLower by 184,674 Prior quarter: 647,069Open filing 0001367401-26-000006 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 454,918 SH4,794,836 dollarsHigher by 3,001 Prior quarter: 451,917Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Edgestream Partners, L.P. Partly reported under another manager454,053 SH4,785,719 dollarsHigher by 227,506 Prior quarter: 226,547Open filing 0001535061-26-000005 Filed 2026-11-10 Dispute this row
FINDELL CAPITAL MANAGEMENT LLC 450,000 SH4,743,000 dollarsNot in the prior quarter’s filings read Open filing 0000921895-26-003181 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager433,054 SH4,564,384 dollarsLower by 7,720 Prior quarter: 440,774Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Gagnon Advisors, LLC 432,186 SH4,555,240 dollarsHigher by 191,089 Prior quarter: 241,097Open filing 0001019056-26-000153 Filed 2026-11-06 Dispute this row
BRIDGEWAY CAPITAL MANAGEMENT, LLC 391,123 SH4,122,436 dollarsLower by 7,966 Prior quarter: 399,089Open filing 0001107261-26-000007 Filed 2026-11-16 Dispute this row
Public Sector Pension Investment Board 348,761 SH4,962,869 dollarsHigher by 114,484 Prior quarter: 234,277Open filing 0001396318-26-000039 Filed 2026-11-10 Dispute this row
CITIGROUP INC Partly reported under another manager329,286 SH3,470,674 dollarsHigher by 294,576 Prior quarter: 34,710Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
PRINCIPAL FINANCIAL GROUP INC Partly reported under another manager327,745 SH3,454,433 dollarsLower by 1,835 Prior quarter: 329,580Open filing 0001126328-26-000225 Filed 2026-11-02 Dispute this row
TUDOR INVESTMENT CORP ET AL 324,734 SH3,422,696 dollarsHigher by 129,781 Prior quarter: 194,953Open filing 0000902664-26-004567 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager308,926 SH3,256,081 dollarsLower by 262,000 Prior quarter: 570,926Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
HRT FINANCIAL LP 304,049 SH3,204 dollarsHigher by 203,749 Prior quarter: 100,300Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager283,581 SH2,988,944 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Aristotle Capital Boston, LLC Partly reported under another manager276,056 SH2,909,633 dollarsLower by 74,089 Prior quarter: 350,145Open filing 0001398344-26-020095 Filed 2026-11-16 Dispute this row
AYAL Capital Advisors Ltd 275,000 SH2,898,500 dollarsHigher by 95,000 Prior quarter: 180,000Open filing 0000929638-26-004328 Filed 2026-11-16 Dispute this row
GAMCO INVESTORS, INC. ET AL 261,140 SH2,752,416 dollarsHigher by 9,905 Prior quarter: 251,235Open filing 0001140361-26-043449 Filed 2026-11-12 Dispute this row
Empowered Funds, LLC Partly reported under another manager260,023 SH2,740,642 dollarsLower by 7,966 Prior quarter: 267,989Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row
Nuveen, LLC Partly reported under another manager252,863 SH2,665,176 dollarsHigher by 32,128 Prior quarter: 220,735Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 1,018,104 SH
  • Lightrock Netherlands B.V. 290,547 SH
  • Ballast Asset Management, LP 144,526 SH
  • D. E. Shaw Co., Inc. 128,500 SH
  • BEACONLIGHT CAPITAL, LLC 102,800 SH
  • Summit Trail Advisors, LLC 99,157 SH
  • KENNEDY CAPITAL MANAGEMENT LLC 89,293 SH
  • Y-Intercept (Hong Kong) Ltd 87,117 SH
  • Monaco Asset Management SAM 65,000 SH
  • WEDGE CAPITAL MANAGEMENT L L P/NC 53,623 SH
  • SYSTEMATIC FINANCIAL MANAGEMENT LP 45,235 SH
  • FRANKLIN RESOURCES INC 38,662 SH
  • Jupiter Topco LLC 28,993 SH
  • Mariner, LLC 27,962 SH
  • GSA CAPITAL PARTNERS LLP 27,961 SH
  • Curated Wealth Partners LLC 27,307 SH
  • MIRABELLA FINANCIAL SERVICES LLP 27,172 SH
  • Verdence Capital Advisors LLC 26,918 SH
  • Orion Porfolio Solutions, LLC 26,347 SH
  • Allspring Global Investments Holdings, LLC 23,253 SH
  • Corient Private Wealth LP 20,741 SH
  • Cerity Partners LLC 19,948 SH
  • TWO SIGMA INVESTMENTS, LP 17,402 SH
  • RAYMOND JAMES FINANCIAL INC 13,722 SH
  • INTECH INVESTMENT MANAGEMENT LLC 13,253 SH
  • Bayforest Capital Ltd 12,581 SH
  • INSPIRION WEALTH ADVISORS, LLC 11,466 SH
  • Linden Thomas Advisory Services, LLC 10,806 SH
  • Merit Financial Group, LLC 10,432 SH
  • CAPTRUST FINANCIAL ADVISORS 10,080 SH
  • LSV ASSET MANAGEMENT 9,200 SH
  • Ensign Peak Advisors, Inc 4,343 SH
  • Integrated Wealth Concepts LLC 3,050 SH
  • ALL OPTIONS USA, LLC 2,800 SH
  • Aster Capital Management (DIFC) Ltd 585 SH
  • Optiver Holding B.V. 463 SH
  • NATIONAL BANK OF CANADA /FI/ 234 SH
  • Quarry LP 200 SH
  • Wealth Enhancement Trust Services, Inc. 155 SH
  • HUNTINGTON NATIONAL BANK 126 SH
  • INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 126 SH
  • Silver Grove Financial Group, Inc. 117 SH
  • Bogart Wealth, LLC 83 SH
  • ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ 76 SH
  • Keating Financial Advisory Services, Inc. 54 SH
  • Physician Wealth Advisors, Inc. 42 SH
  • Plante Moran Financial Advisors, LLC 23 SH
  • Synergy Investment Management, LLC 20 SH
  • Capital Advisors, Ltd. LLC 19 SH
  • Transamerica Financial Advisors, LLC 15 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–1 of 1

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Daniel Goldman (NY10)2023-07-12Sale$1,001 - $15,0002023-08-13

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Newtyn Management, LLC Common Stock, par value $0.001 per share7.85,342,283.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 3Open filing 0001493152-26-052316 Dispute this row
Newtyn TE Partners, LP Common Stock, par value $0.001 per share5.03,443,720.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 3Open filing 0001493152-26-052316 Dispute this row
FMR LLC COMMON STOCK5.83,950,167.6709/30/2026 Filed 2026-10-07SCHEDULE 13G/AAmendment 4Open filing 0000315066-26-002330 Dispute this row
Abigail P. Johnson COMMON STOCK5.83,950,167.6709/30/2026 Filed 2026-10-07SCHEDULE 13G/AAmendment 4Open filing 0000315066-26-002330 Dispute this row
Neuberger Berman Group LLC Common4.93,381,189.0007/31/2026 Filed 2026-08-05SCHEDULE 13G/AAmendment 1Open filing 0001465109-26-000063 Dispute this row
Neuberger Berman Investment Advisers LLC Common4.43,030,743.0007/31/2026 Filed 2026-08-05SCHEDULE 13G/AAmendment 1Open filing 0001465109-26-000063 Dispute this row
T. Rowe Price Investment Management, Inc. COMMON STOCK2.61,743,56306/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 6Open filing 0001897612-26-000616 Dispute this row
Newtyn Management, LLC Common Stock9.76,625,000.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001493152-26-038377 Dispute this row
Newtyn TE Partners, LP Common Stock6.34,266,500.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001493152-26-038377 Dispute this row
Invesco Ltd. Common Stock5.13,473,432.0006/30/2026 Filed 2026-08-13SCHEDULE 13GOpen filing 0000914208-26-000307 Dispute this row
Neuberger Berman Group LLC Common5.23,534,619.0006/30/2026 Filed 2026-07-08SCHEDULE 13GOpen filing 0001465109-26-000061 Dispute this row
Neuberger Berman Investment Advisers LLC Common4.73,202,589.0006/30/2026 Filed 2026-07-08SCHEDULE 13GOpen filing 0001465109-26-000061 Dispute this row
FMR LLC COMMON STOCK11.57,852,321.8104/30/2026 Filed 2026-05-07SCHEDULE 13G/AAmendment 3Open filing 0000315066-26-001377 Dispute this row
Abigail P. Johnson COMMON STOCK11.57,852,321.8104/30/2026 Filed 2026-05-07SCHEDULE 13G/AAmendment 3Open filing 0000315066-26-001377 Dispute this row
Newtyn Management, LLC Common Stock7.85,300,000.0004/29/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 1Open filing 0001493152-26-021494 Dispute this row
Newtyn TE Partners, LP Common Stock5.03,418,500.0004/29/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 1Open filing 0001493152-26-021494 Dispute this row
Newtyn Management, LLC Common Stock6.74,558,472.0003/31/2026 Filed 2026-05-06SCHEDULE 13GOpen filing 0001493152-26-021492 Dispute this row
FMR LLC COMMON STOCK9.76,591,151.5403/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 2Open filing 0000315066-26-001298 Dispute this row
Abigail P. Johnson COMMON STOCK9.76,591,151.5403/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 2Open filing 0000315066-26-001298 Dispute this row
Invesco Ltd. Common Stock4.63,117,469.0003/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 1Open filing 0000914208-26-000154 Dispute this row
Vanguard Capital Management Common Stock5.243,572,56303/31/2026 Filed 2026-04-30SCHEDULE 13GOpen filing 0002100119-26-001016 Dispute this row
Vanguard Portfolio Management Common Stock64,088,16803/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100121-26-000606 Dispute this row
T. Rowe Price Investment Management, Inc. COMMON STOCK8.35,629,96503/31/2026 Filed 2026-04-08SCHEDULE 13G/AAmendment 5Open filing 0001897612-26-000343 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 6Open filing 0000102909-26-002144 Dispute this row
Rubric Capital Management LP Common Stock, par value $0.001 per share5.563,777,157.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 3Open filing 0001104659-26-015233 Dispute this row
David Rosen Common Stock, par value $0.001 per share5.563,777,157.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 3Open filing 0001104659-26-015233 Dispute this row
Invesco Ltd. Common Stock5.13,470,656.0012/31/2025 Filed 2026-02-12SCHEDULE 13GOpen filing 0000914208-26-000054 Dispute this row
FMR LLC COMMON STOCK8.05,420,217.8512/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-000528 Dispute this row
Abigail P. Johnson COMMON STOCK8.05,420,217.8512/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-000528 Dispute this row
FMR LLC COMMON STOCK6.64,496,153.4309/30/2025 Filed 2025-11-05SCHEDULE 13GOpen filing 0000315066-25-002831 Dispute this row
Abigail P. Johnson COMMON STOCK6.64,496,153.4309/30/2025 Filed 2025-11-05SCHEDULE 13GOpen filing 0000315066-25-002831 Dispute this row
Invesco Ltd. Common Stock2.31,554,260.0006/30/2025 Filed 2025-08-07SCHEDULE 13G/AAmendment 1Open filing 0000914208-25-000297 Dispute this row
The Vanguard Group Common Stock11.527,796,46206/30/2025 Filed 2025-07-29SCHEDULE 13G/AAmendment 5Open filing 0000932471-25-000988 Dispute this row
BlackRock, Inc. Common Stock14.89,995,33606/30/2025 Filed 2025-07-17SCHEDULE 13G/AAmendment 5Open filing 0002052113-25-003168 Dispute this row
Rubric Capital Management LP Common Stock, par value $0.001 per share6.864,637,738.0006/30/2025 Filed 2025-07-09SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-066709 Dispute this row
David Rosen Common Stock, par value $0.001 per share6.864,637,738.0006/30/2025 Filed 2025-07-09SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-066709 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,687,210 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to QUIDELORTHO CORP